DIGESTIVE TRIM FORMULA
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Healthy Natural Systems
- NPN or DIN-HM
- 80049158
- Status
- Active licence
- Licence date
- 11 March 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,4-bêta-D-mannane mannanohydrolase Source : Trichoderma reesei - en entier Potency : 15 FCC HCU | 3.75 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 6,000 FCC HUT | 60 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier Potency : 37.5 FCC SU | 0.75 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier Potency : 30 FCC CU | 0.3 mg | Not calculated |
| Camellia sinensis Source : leaf standardized extract Potency : 75 % Catechins | 100 mg | Not calculated |
| Camellia sinensis Source : leaf standardized extract Potency : 3 % Caffeine | Not specified | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Trichoderma reesei - en entier Potency : 3 XU | 3 mg | Not calculated |
| Garcinia cambogia Source : Fruit rind extract - standardized Potency : 50 % hydroxycitric acid | 125 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier Potency : 3 FCC LU | 0.3 mg | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus niger - En entier Potency : 3.75 Endo-PG | 0.75 mg | Not calculated |
| Mentha x piperita Source : Feuille | 16.5 mg | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger - En entier Potency : 3.75 FCC FTU | 0.75 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 4,500 FCC HUT | 9 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 3,000 FCC HUT | 30 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens Potency : 1,500 FCC SU | 15 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier Potency : 15 FCC GalU | 1.5 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - Cellule entière Potency : 750 FCC DU | 7.5 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière Potency : 375 FCC PC | 3.75 mg | Not calculated |
| Lagerstroemia speciosa Source : leaf standardized extract Potency : 1 % Corosolic acid | 8 mg | Not calculated |
| Bêta-D-galactoside galactohydrolase Source : Aspergillus flavus var. oryzae - En entier Potency : 61.5 FCC ALU | 1.65 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Phosphate de calcium, dibasique, Poly(éthylène glycol), Acide stéarique, Silice, Croscarmellose de sodium, Hypromellose, Maltodextrine, Spirulina platensis whole
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme. Digestive aid. Helps digest proteins. A factor in the maintenance of good health. Provides support for healthy glucose metabolism. Helps the body to matabolize carbohydrates and fats. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80049158
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.